Concepedia

SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment

Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, I. Castellví, Esteban Cano-Jiménez, Natalia Mena‐Vázquez, Maria Asunción Nieto, Ana María Ortiz,

Reumatología Clínica (English Edition) · 2022 · 23 citations · 68 references

DOI

Concepts

References

68

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

, , +11

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

, , +10

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

Paul M. Ridker, Brendan M. Everett, Aruna D. Pradhan et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

, , +16

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1.1K citations

, , +11

Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study

Tim Bongartz, Carlotta Nannini, Yimy F. Medina et al. · Arthritis & Rheumatism · 2010 · 860 citations

, , +14